Allergologie select, Volume 7 (2023) - 1st issue (191 - 197)

Management of allergic rhinitis improves clinical outcomes of difficult-to-treat tic disorders or attention-deficit/hyperactivity disorders
Rui-Li Yu1, Jing Wang2, Xue-Song Wang3, Hong-Tian Wang1, Xue-Yan Wang1
1 Department of Allergy, Beijing Shijitan Hospital, Capital Medical University, 2 Department of Pediatrics, First Medical Center, PLA General Hospital, Beijing, and 3 Department of Otolaryngology, Binzhou Central Hospital Affiliated to Binzhou Medical College, Binzhou, Shandong, China

Add to Cart  

 

DOI 10.5414/ALX400588E

Abstract

Aims: This case series aimed to evaluate the effects of treatment for allergic rhinitis (AR) in AR-diagnosed children with previous diagnosis of tic disorders/attention-deficit/hyperactivity disorders (TD/ADHD) but unresponsive to behavioral or medical treatment. Materials and methods: Between July 2016 and June 2021, children diagnosed with AR in our hospital were enrolled. All were diagnosed with TD/ADHD refractory to behavioral or medical treatment. The demography and clinical information were collected from medical records. The outcomes were visual analogue scale (VAS) for AR severity, Yale Comprehensive Tic Severity Scale (YGTSS) for TD symptoms, and Attention-Deficit Hyperactivity Screening Scale (SNAP-IV) for ADHD symptoms. Results: A total of 27 children (18 boys, 9 girls) were included, with a mean age 7.4 ± 2.9 years (3 – 17 years). They had undergone behavioral or medical treatment of TD/ADHD for 3.6 ± 1.9 years but without significant improvement in TD/ADHD symptoms. After 2-6 months of systematic treatment for AR, VAS was decreased to 0.4 ± 0.1 from 0.8 ± 0.2, YGTSS to 3.5 ± 0.7 from 6.8 ± 1.4, and SNAP-IV to 0.4 ± 0.1 from 0.6 ± 0.2 (all p < 0.001). No recurrence of TD/ADHD symptoms was reported during a mean follow-up of 2.4 ± 1.1 years (0.5 – 5 years). Conclusion: AR treatment improves TD/ADHD outcomes in children with difficult-to-treat TD/ADHD. In TD/ADHD children who are unresponsive to behavioral or drug treatment and have AR-related symptoms, AR examination and treatment are recommended for better prognosis.

Author Details

Authors

Departments

  • 1 Department of Allergy, Beijing Shijitan Hospital, Capital Medical University,
  • 2 Department of Pediatrics, First Medical Center, PLA General Hospital, Beijing, and
  • 3 Department of Otolaryngology, Binzhou Central Hospital Affiliated to Binzhou Medical College, Binzhou, Shandong, China

Address

Hong-Tian Wang, PhD, Department of Allergy, Beijing Shijitan Hospital, Capital Medical University, 10 Tieyi Road, Yangfangdian, Haidian District, Beijing, China, 100038
Email: [email protected]

Citation

Rui-Li Yu, Jing Wang, Xue-Song Wang, Hong-Tian Wang, and Xue-Yan Wang.Management of allergic rhinitis improves clinical outcomes of difficult-to-treat tic disorders or attention-deficit/hyperactivity disorders. Allergologie Select. 2023; 7: 191-197. doi: 10.5414/ALX400588E.

###article_not_exists_msg###

Warenkorb Übersicht

Warenkorb Übersicht
Typ Anz Rabatt MwSt Preis
Der Warenkorb ist leer
Ihr Warenkorb